title: Ovarian and PGF2α responses to stimulation of endogenous PRL pulses during the estrous cycle in mares.
abstract: The effects of a PRL-stimulating substance (sulpiride) on PRL and PGF2α secretion and on luteal and ovarian follicular dynamics were studied during the estrous cycle in mares. A control group (n = 9) and a sulpiride group (Sp; n = 10) were used. Sulpiride (25 mg) was given every 8 h from Day 13 postovulation to the next ovulation. Repeated sulpiride treatment did not appear to maintain PRL concentrations at 12-h intervals beyond Day 14. Therefore, the hypothesis that a long-term increase in PRL altered luteal and follicular end points was not testable. Hourly samples were collected from the hour of a treatment (Hour 0) to Hour 8 on Day 14. Concentrations of PRL increased to maximum at Hour 4 in the Sp group. The PRL pulses were more prominent (P < 0.008) in the sulpiride group (peak, 19.4 ± 1.9 ng/mL; mean ± SEM) than in the controls (11.5 ± 1.8 ng/mL). Concentrations of a metabolite of PGF2α (PGFM), number, and characteristics of PGFM pulses, and concentrations of progesterone during Hours 0 to 8 were not affected by the increased PRL. A novel observation was that the peak of a PRL pulse occurred at the same hour or 1 h later than the peak of a PGFM pulse in 8 of 8 PGFM pulses in the controls and in 6 of 10 pulses in the Sp group (P < 0.04), indicating that sulpiride interfered with the synchrony between PGFM and PRL pulses. The hypothesis that sulpiride treatment during the equine estrous cycle increases concentrations of PRL and the prominence of PRL pulses was supported.
authors: Eutheria Foundation, Cross Plains, Wisconsin, USA.
authors: F L V
authors: FL
authors: Pinaffi
authors: F A
authors: FA
authors: Khan
authors: L A
authors: LA
authors: Silva
authors: M A
authors: MA
authors: Beg
authors: O J
authors: OJ
authors: Ginther
mesh_terms: D000818:Animals; D015237:Dinoprost / Q000031:analogs & derivatives / Q000378:metabolism*; D030762:Estrous Cycle / Q000187:drug effects / Q000502:physiology*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D006736:Horses / Q000502:physiology*; D007986:Luteinizing Hormone / Q000378:metabolism; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D013469:Sulpiride / Q000494:pharmacology*
chemical_list: C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D013469:Sulpiride; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D015237:Dinoprost